Stonepine Capital Management Reports 0.3% Stake in Edesa Biotech, Inc.

Stonepine Capital Management, LLC, along with affiliated entities Stonepine Capital, L.P., Stonepine GP, LLC, and control person Jon M. Plexico, filed a Schedule 13G/A for Edesa Biotech, Inc. (EDSA) on May 15, 2026. The filing indicates a new collective ownership position of 30,000 shares of Common Stock, representing 0.3% of the class based on 8,891,951 shares outstanding as of May 13, 2026. This represents an increase from a previous ownership level of 0.0%. The reporting persons share voting and dispositive power over the reported shares. Stonepine Capital Management serves as the investment adviser, while Stonepine GP, LLC serves as the general partner to Stonepine Capital, L.P. The filing was made to report holdings as of the event date of March 31, 2026. The reporting persons certified that the securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. Consequently, the importance of this filing is rated as low due to the small percentage of ownership.